Cancer BioMarker vaccine
A Cancer Biomarker Vaccine is a type of vaccine designed to target specific molecules, proteins, or genetic markers that are indicative of cancer cells. These biomarkers can be unique to cancer cells or overexpressed compared to normal cells, making them potential targets for therapy.
The concept behind this vaccine is to stimulate the body's immune system to recognize and attack cells displaying these specific biomarkers, thereby targeting and destroying cancerous cells while sparing healthy ones. Essentially, it's a form of immunotherapy, harnessing the body's own immune defenses to fight cancer.
Related Conference of Cancer BioMarker vaccine
April 22-23, 2025
8th International Conference on Vaccines, Immunology and Clinical Trials
Paris, France
Cancer BioMarker vaccine Conference Speakers
Recommended Sessions
- One Health Approach
- Cancer BioMarker vaccine
- COVID19 Vaccines
- Geriatric Vaccines
- Global Vaccine Access
- Immunology of Vaccines
- Next Generation Vaccines
- Novel Vaccine Platforms
- Paediatric Vaccines
- Vaccine Adjuvants
- Vaccine Clinical Trials
- Vaccine Delivery Systems
- Vaccine Development for Emerging Diseases
- Vaccine Equity
- Vaccine Financing
- Vaccine Hesitancy
- Vaccine Immunogenicity
- Vaccine Manufacturing
- Vaccine Policy and Regulation
- Vaccine Safety
- Vaccine Surveillance
- Vaccines Epidemiology
- Vaccines Immunology
Related Journals
Are you interested in
- Adjuvants and Immunomodulators in Vaccines - Vaccine Immunology 2024 (France)
- Advancements in Vaccine Adjuvants - Vaccines R&D 2025 (France)
- Advances in Vaccine Development - WORLD VACCINES 2025 (France)
- Advances in Vaccine Safety Monitoring - Vaccines R&D 2025 (France)
- AI & Big Data in Vaccine Research - VACCINE CONGRESS 2025 (UAE)
- Antimicrobial Resistance (AMR) - VACCINE CONGRESS 2025 (UAE)
- Antimicrobial Resistance (AMR) - VACCINES WORLD 2025 (Italy)
- Bioinformatics and Vaccine Design - Vaccine Immunology 2024 (France)
- Biomarkers and Immune Monitoring in Vaccines - WORLD VACCINES 2025 (France)
- Bioprocessing and Manufacturing - VACCINES WORLD 2025 (Italy)
- Biosecurity and Bioterrorism Preparedness - GLOBAL VACCINE 2025 (Indonesia)
- Cancer Vaccines - Vaccines Congress-2024 (Canada)
- Cancer Vaccines and Immunotherapy - GLOBAL VACCINE 2025 (Indonesia)
- Cancer Vaccines and Immunotherapy - VACCINE CONGRESS 2025 (UAE)
- Cancer Vaccines and Immunotherapy - VACCINES WORLD 2025 (Italy)
- Challenges in Vaccine Accessibility and Equity - Vaccine Immunology 2024 (France)
- Clinical Trials - VACCINE CONGRESS 2025 (UAE)
- Clinical Trials - VACCINES WORLD 2025 (Italy)
- Clinical Trials and Regulatory Affairs - GLOBAL VACCINE 2025 (Indonesia)
- Clinical Trials and Vaccine Research - Vaccines R&D 2025 (France)
- Combination & Conjugate Vaccines - Vaccines Congress-2024 (Canada)
- Community Engagement and Public Health Campaigns - Vaccines R&D 2025 (France)
- Computational Immunology and Vaccine Modeling - WORLD VACCINES 2025 (France)
- Conjugate Vaccine - GLOBAL VACCINE 2025 (Indonesia)
- Conjugate Vaccine - VACCINES WORLD 2025 (Italy)
- Coronavirus (COVID-19) & Pandemic Vaccines - VACCINES WORLD 2025 (Italy)
- COVID-19 Vaccine - VACCINE CONGRESS 2025 (UAE)
- DNA, RNA & Synthetic Vaccines - Vaccines Congress-2024 (Canada)
- DNA-RNA Vaccines - VACCINES WORLD 2025 (Italy)
- Emerging and Re-Emerging Diseases - VACCINES WORLD 2025 (Italy)
- Emerging Infectious Disease Vaccines - VACCINE CONGRESS 2025 (UAE)
- Emerging Infectious Diseases - Vaccine Immunology 2024 (France)
- Emerging Infectious Diseases and Vaccine Responses - WORLD VACCINES 2025 (France)
- Emerging Technologies in Diagnostics - GLOBAL VACCINE 2025 (Indonesia)
- Environmental and Societal Impact on Vaccine Development - Vaccine Immunology 2024 (France)
- Epidemiology and Public Health - GLOBAL VACCINE 2025 (Indonesia)
- Ethics and Public Policy in Vaccination - Vaccines R&D 2025 (France)
- Fungal/Bacterial/Viral/Parasitic/STD Vaccines - VACCINES WORLD 2025 (Italy)
- Future Directions in Vaccine Research - Vaccine Immunology 2024 (France)
- Global Vaccination Strategies - Vaccine Immunology 2024 (France)
- Global Vaccine Distribution Challenges - Vaccines R&D 2025 (France)
- Global Vaccine Equity - VACCINE CONGRESS 2025 (UAE)
- HIV Vaccines - GLOBAL VACCINE 2025 (Indonesia)
- HIV Vaccines - VACCINE CONGRESS 2025 (UAE)
- HIV Vaccines - VACCINES WORLD 2025 (Italy)
- HIV, Malaria & TB Vaccines - Vaccines Congress-2024 (Canada)
- Human Microbiome and Vaccines - Vaccine Immunology 2024 (France)
- Human Vaccines Against Infectious Diseases - Vaccines Congress-2024 (Canada)
- Human Vaccines Against Infectious Diseases - Vaccines Congress-2024 (Canada)
- Immune Profiling - VACCINES WORLD 2025 (Italy)
- Immunization in Special Populations - Vaccine Immunology 2024 (France)
- Immunization Programs and Strategies - GLOBAL VACCINE 2025 (Indonesia)
- Immunogenetics and Personalized Vaccines - Vaccine Immunology 2024 (France)
- Immunogenetics and Vaccine Design - WORLD VACCINES 2025 (France)
- Immunological Memory and Vaccine Boosters - WORLD VACCINES 2025 (France)
- Immunology Advances and Vaccine Efficacy - Vaccines R&D 2025 (France)
- Immunology of Aging and Vaccination - Vaccine Immunology 2024 (France)
- Immunology of Infectious Diseases - Vaccine Immunology 2024 (France)
- Immunotherapy and Autoimmune Diseases - Vaccine Immunology 2024 (France)
- Immunotherapy and Cancer Vaccines - WORLD VACCINES 2025 (France)
- Immunotherapy in Cancer Treatment - Vaccine Immunology 2024 (France)
- Impact of Climate Change on Infectious Disease and Vaccination - Vaccines R&D 2025 (France)
- Infectious and Non-Infectious Diseases - VACCINE CONGRESS 2025 (UAE)
- Infectious and Non-Infectious Diseases - VACCINES WORLD 2025 (Italy)
- Influenza & Respiratory Virus Vaccines - VACCINE CONGRESS 2025 (UAE)
- Influenza and Respiratory Vaccines - VACCINES WORLD 2025 (Italy)
- Innovations in Vaccine Development and Delivery - Vaccine Immunology 2024 (France)
- Innovations in Vaccine Formulation and Delivery - Vaccines R&D 2025 (France)
- Innovative Vaccine Delivery Systems - WORLD VACCINES 2025 (France)
- Innovative Vaccine Development - GLOBAL VACCINE 2025 (Indonesia)
- Innovative Vaccine Technologies - Vaccines R&D 2025 (France)
- Integration of Digital Health in Immunization - Vaccines R&D 2025 (France)
- Maternal and Neonatal Immunization - Vaccine Immunology 2024 (France)
- mRNA Vaccine Innovations - VACCINE CONGRESS 2025 (UAE)
- Mucosal Immunology and Vaccination - WORLD VACCINES 2025 (France)
- Nanotechnology in Vaccine Delivery - Vaccine Immunology 2024 (France)
- Nanotechnology in Vaccine Development - WORLD VACCINES 2025 (France)
- Nanotechnology in vaccines - GLOBAL VACCINE 2025 (Indonesia)
- New Trends in Vaccines Development - Vaccines Congress-2024 (Canada)
- Next-Generation Sequencing in Immunology Research - WORLD VACCINES 2025 (France)
- Next-Generation Vaccine Delivery Technologies - GLOBAL VACCINE 2025 (Indonesia)
- Novel Adjuvants & Delivery Systems - VACCINE CONGRESS 2025 (UAE)
- Novel Vaccine Platforms: mRNA, DNA, and Viral Vectors - Vaccine Immunology 2024 (France)
- One Health Approach to Vaccine Development - Vaccine Immunology 2024 (France)
- One Health: Zoonotic Disease Vaccines - VACCINE CONGRESS 2025 (UAE)
- Pandemic Preparedness and Response - Vaccine Immunology 2024 (France)
- Pandemic Preparedness and Response - GLOBAL VACCINE 2025 (Indonesia)
- Pediatric Vaccination: Challenges and Opportunities - Vaccine Immunology 2024 (France)
- Pediatric Vaccines and Immunization Strategies - WORLD VACCINES 2025 (France)
- Pediatric Vaccines: Trends & Future - VACCINE CONGRESS 2025 (UAE)
- Personalized Immunization Strategies - Vaccines R&D 2025 (France)
- Personalized Vaccinology - VACCINE CONGRESS 2025 (UAE)
- Rapid Vaccine Development and Deployment - Vaccines R&D 2025 (France)
- RDT in Antibiotic Research - Vaccines Congress-2024 (Canada)
- Regulatory Pathways in Vaccines - VACCINE CONGRESS 2025 (UAE)
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) - Vaccines Congress-2024 (Canada)
- Side-effects of Vaccines - Vaccines Congress-2024 (Canada)
- Technological Innovations in Vaccinology - GLOBAL VACCINE 2025 (Indonesia)
- The Economics of Vaccination - Vaccine Immunology 2024 (France)
- Therapeutic Vaccines for Chronic Diseases - WORLD VACCINES 2025 (France)
- Thermo Stabilized Vaccines - VACCINES WORLD 2025 (Italy)
- Thermo-stabilized vaccines - GLOBAL VACCINE 2025 (Indonesia)
- Toxoid Vaccines - Vaccines Congress-2024 (Canada)
- Travel medicine and vaccines - Vaccines Congress-2024 (Canada)
- Vaccination in Special Populations - Vaccines R&D 2025 (France)
- Vaccine Access and Equity - GLOBAL VACCINE 2025 (Indonesia)
- Vaccine Adjuvants - GLOBAL VACCINE 2025 (Indonesia)
- Vaccine Adjuvants - VACCINES WORLD 2025 (Italy)
- Vaccine Adjuvants and Immunomodulators - WORLD VACCINES 2025 (France)
- Vaccine and Vaccination - Vaccines Congress-2024 (Canada)
- Vaccine Clinical Trials: Design and Implementation - Vaccine Immunology 2024 (France)
- Vaccine Development for Neglected Tropical Diseases - Vaccine Immunology 2024 (France)
- Vaccine Development for Zoonotic Diseases - WORLD VACCINES 2025 (France)
- Vaccine Hesitancy & Public Engagement - VACCINE CONGRESS 2025 (UAE)
- Vaccine Hesitancy and Public Health Communication - WORLD VACCINES 2025 (France)
- Vaccine Hesitancy and Public Trust - Vaccine Immunology 2024 (France)
- Vaccine Innovation for Emerging Diseases - Vaccines R&D 2025 (France)
- Vaccine Manufacturing Advances - VACCINE CONGRESS 2025 (UAE)
- Vaccine Policy and Regulation - Vaccine Immunology 2024 (France)
- Vaccine Policy and Regulatory Affairs - WORLD VACCINES 2025 (France)
- Vaccine Production & Development - Vaccines Congress-2024 (Canada)
- Vaccine Production and Global Supply Chains - Vaccine Immunology 2024 (France)
- Vaccine Production, Supply & Logistics - VACCINES WORLD 2025 (Italy)
- Vaccine Research & Development - VACCINE CONGRESS 2025 (UAE)
- Vaccine Research and Development - GLOBAL VACCINE 2025 (Indonesia)
- Vaccine Research and Development - VACCINES WORLD 2025 (Italy)
- Vaccine Safety & Immunogenicity - VACCINE CONGRESS 2025 (UAE)
- Vaccine Safety and Adverse Event Monitoring - Vaccine Immunology 2024 (France)
- Vaccine Safety and Efficacy - WORLD VACCINES 2025 (France)
- Vaccine Safety, Efficacy & Regulatory Affairs - VACCINES WORLD 2025 (Italy)
- Vaccine Strategies for Autoimmune Diseases - WORLD VACCINES 2025 (France)
- Vaccine-Induced Immunity and Duration of Protection - Vaccine Immunology 2024 (France)
- Vaccine-Preventable Diseases - VACCINE CONGRESS 2025 (UAE)
- Vaccines and Emerging Diseases - GLOBAL VACCINE 2025 (Indonesia)
- Vaccines Epidemiology & Immunology - VACCINE CONGRESS 2025 (UAE)
- Vaccines for Neglected Tropical Diseases - WORLD VACCINES 2025 (France)
- Vaccines for Pregnant Women - Vaccines Congress-2024 (Canada)
- Vaccines for Unconventional Diseases - Vaccines Congress-2024 (Canada)
- Vaccines Manufacturing Technologies - Vaccines Congress-2024 (Canada)
- Vaccines Research and Clinical Trails - Vaccines Congress-2024 (Canada)
- Veterinary Vaccine - VACCINE CONGRESS 2025 (UAE)
- Veterinary Vaccine - VACCINES WORLD 2025 (Italy)
- Veterinary vaccines - GLOBAL VACCINE 2025 (Indonesia)
- Veterinary Vaccines and Zoonotic Diseases - Vaccine Immunology 2024 (France)
- Zika Virus Vaccines - Vaccines Congress-2024 (Canada)